E-cigarette use during pregnancy and its association with adverse birth outcomes in the US

Prev Med. 2023 Jan:166:107375. doi: 10.1016/j.ypmed.2022.107375. Epub 2022 Dec 5.

Abstract

The popularity of e-cigarette use among young adults is a growing concern. However, little is known about factors associated with e-cigarette use in pregnant women and birth outcomes. In this retrospective cohort study, we evaluated the influence of several factors on behavioral changes in e-cigarette use before and during pregnancy, and assessed the association between e-cigarette use and subsequent birth outcomes among pregnant women. The Population Assessment of Tobacco and Health (PATH) study, a government-sponsored national longitudinal study based in the US, Waves 1 through 4 (2013-2018) were used. Multivariate logistic regressions were conducted to estimate behavioral changes in e-cigarette use during pregnancy and subsequent influence on high-risk birth (e.g., preterm birth, low birth weight, birth defects, etc.) and fetal death. Although pregnant women who quit vaping before pregnancy (OR = 1.14, 95% CI 0.54-2.40) or had any use during pregnancy (OR = 1.19, 95% CI 0.38-3.73) showed non-differential risk of having a high-risk birth in comparison to women who did not initiate vaping, we observed that the usage of mint/menthol flavor was correlated with higher risk of fetus death (OR = 3.27, 95% CI 1.17-9.19). Healthcare providers should encourage e-cigarette users to quit prior to and during early pregnancy.

Keywords: E-cigarettes; High-risk birth; Pregnant; Smoking cessation; Vape flavors.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Electronic Nicotine Delivery Systems*
  • Female
  • Flavoring Agents
  • Humans
  • Infant, Newborn
  • Longitudinal Studies
  • Pregnancy
  • Pregnancy Complications*
  • Premature Birth* / epidemiology
  • Retrospective Studies
  • Tobacco Products*
  • Vaping* / adverse effects
  • Vaping* / epidemiology
  • Young Adult

Substances

  • Flavoring Agents